Columbus OH 乳腺癌临床试验
39项针对 乳腺癌的研究正在 Columbus及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- 以及另外 8 项
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
招募中2 期
- The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
招募中1 期
- James Cancer Hospital and Solove Research Institute, Columbus
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
招募中1/2 期
- Local Institution - 0102, Columbus
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
招募中3 期
- Clinical Trial Site, Columbus
- Clinical Trial Site, Columbus
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
招募中3 期
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
招募中1 期
- The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc., Columbus
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
招募中1 期
- The Ohio State University (OSU) Wexner Medical Center, Columbus
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
招募中3 期
- Ohio State University Comprehensive Cancer Center, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- Riverside Methodist Hospital, Columbus
- 以及另外 8 项
ATEMPT 2.0: Adjuvant T-DM1 vs TH
招募中2 期
- Stefanie Spielman Comprehensive Breast Center, Columbus
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
招募中3 期
- Ohio State University Comprehensive Cancer Center, Columbus
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
招募中2 期欢迎健康志愿者
- Ohio State University Comprehensive Cancer Center, Columbus
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
招募中1/2 期
- Ohio State University Comprehensive Cancer Center (OSUCCC)- The James Cancer Hospital and Solove Research Institute, Columbus
E-Mindfulness Approaches for Living After Breast Cancer
招募中3 期
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Mount Carmel Grove City Hospital, Grove City · 距离 7 英里
- 以及另外 2 项
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
招募中2 期
- The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
招募中1/2 期
- Stefanie Spielman Comprehensive Breast Center, Columbus
Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
招募中4 期
- Ohio State University Comprehensive Cancer Center, Columbus
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
招募中2 期
- Ohio State University Comprehensive Cancer Center, Columbus
A Pilot Study to Evaluate the Effectiveness of Focused Massage on Pain, Mobility, and Quality of Life During Radiation Treatment for Patients With Breast Cancer
招募中
- The Ohio State University, Columbus
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
招募中3 期
- The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - , Columbus
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
招募中观察性研究
- Ohio State University Comprehensive Cancer Center, Columbus
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
招募中1 期
- Ohio State University-James Cancer Hospital and Solove Research Institute, Columbus
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
招募中2 期
- Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
招募中3 期
- Stefanie Spielman Comprehensive Breast Center at Olentangy River Road, Columbus
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
招募中2 期
- The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
招募中2 期
- Ohio State University Medical Center, Columbus
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
招募中3 期
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Riverside Methodist Hospital, Columbus
- 以及另外 8 项
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
招募中观察性研究
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
招募中1/2 期
- Stefanie Spielman Comprehensive Breast Center, Columbus
Living Well With Advanced Breast Cancer
招募中观察性研究欢迎健康志愿者
- Ohio State University Comprehensive Cancer Center, Columbus
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中观察性研究
- Memorial Hospital, Marysville · 距离 27 英里
Feasibility Study of CBCT for IGRT in Cancer Patients
招募中
- James Outpatient Center, Columbus
- Ohio State University, Brain and Spine Hospital, Columbus
- The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus
- 以及另外 1 项
The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients
招募中观察性研究
- Ohio State University Comprehensive Cancer Center, Columbus
The Ohio State University (OSU) SCREEN Community Program
招募中欢迎健康志愿者
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
招募中1/2 期
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY
招募中2 期
- The Ohio State University, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Columbus
Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer
招募中
- Ohio State University Comprehensive Cancer Center, Columbus
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
招募中观察性研究
- Mount Carmel West Hospital, Columbus
其他城市的 乳腺癌试验
- New York City, NY134 项研究
- Houston, TX126 项研究
- Boston, MA111 项研究
- Nashville, TN80 项研究
- Los Angeles, CA72 项研究
- Edison, NJ68 项研究
- St. Louis, MO64 项研究
- Durham, NC63 项研究
- Queens, NY63 项研究
- Chicago, IL58 项研究
- Philadelphia, PA56 项研究
- Dallas, TX55 项研究
Columbus的其他研究
- 非小细胞肺癌56 项研究
- 卵巢癌39 项研究
- 癌症（所有类型）38 项研究
- 肺癌37 项研究
- 急性髓系白血病35 项研究
- 慢性淋巴细胞白血病28 项研究
- 转移性癌症27 项研究
- 子宫内膜癌25 项研究
- 结直肠癌24 项研究
- 前列腺癌24 项研究
- 多发性骨髓瘤24 项研究
- 黑色素瘤21 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。